Crimean-Congo Hemorrhagic Fever, Kosovo, 2013-2016

• Published in: Emerging infectious diseases Vol. 25; no. 2; pp. 321 - 324
• Main Authors: Ahmeti, Salih, Berisha, Lindita, Halili, Bahrije, Ahmeti, Florim, von Possel, Ronald, Thomé-Bolduan, Corinna, Michel, Anett, Priesnitz, Simone, Reisinger, Emil C, Günther, Stephan, Krüger, Andreas, Sherifi, Kurtesh, Jakupi, Xhevat, Hemmer, Christoph J, Emmerich, Petra
• Format: Journal Article
• Language: English
• Published: United States U.S. National Center for Infectious Diseases 01-02-2019; Centers for Disease Control and Prevention
• Subjects: Adolescent; Adult; Aged; Analysis; Biomarkers; bleeding; case fatality rate; CCHF; Child; Child, Preschool; Crimean hemorrhagic fever; Crimean-Congo hemorrhagic fever; Crimean-Congo Hemorrhagic Fever, Kosovo, 2013–2016; Dispatch; Epidemiology; Female; Geography; Hemorrhagic Fever Virus, Crimean-Congo; Hemorrhagic Fever, Crimean - epidemiology; Hemorrhagic Fever, Crimean - history; Hemorrhagic Fever, Crimean - virology; Hemorrhagic fevers; History, 21st Century; Humans; Infant; Infant, Newborn; Kosovo; Kosovo - epidemiology; Male; Medical research; Middle Aged; Odds Ratio; Patient outcomes; Public health; Ribavirin; somnolence; Viral Load; Young Adult; Kosovo; CCHF; LDH; viruses; bleeding; ribavirin; viral load; Kosovo; somnolence; lactate dehydrogenase; case-fatality rate; coma; Crimean-Congo hemorrhagic fever
• ISSN: 1080-6040; 1080-6059
• DOI: 10.3201/eid2502.171999

During 2013-2016, a total of 32 patients were treated for Crimean-Congo hemorrhagic fever in Prishtina, Kosovo; 11 died. In the 11 patients who died, findings included viral loads >1 × 10
/mL, lactate dehydrogenase >2,700 U/mL, bleeding, and impaired consciousness. Ribavirin therapy had no noticeable effect in this small patient sample.